AngioDynamics

AngioDynamics Treasury Stock

The Treasury Stock of AngioDynamics (ANGO) as of Nov 4, 2026 is 628.70 M USD. In the previous year, Treasury Stock was 613.81 M USD — a change of 2.43% (higher).

Treasury Stock

628.70 MUSD

YoY

2.43%

Last updated:

Treasury Stock of AngioDynamics is 2026 628.70 M USD. Treasury Stock of AngioDynamics was 2025 613.81 M USD. It decreases by 2.43% higher compared to the previous year.

The AngioDynamics Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2019
549.33 M USD
Jan 1, 2020
556.16 M USD
Jan 1, 2021
567.79 M USD
Jan 1, 2022
581.17 M USD
Jan 1, 2023
593.49 M USD
Jan 1, 2024
604.77 M USD
Jan 1, 2025
613.81 M USD
Jan 1, 2026
628.70 M USD
The AngioDynamics Treasury Stock history
YEARTreasury StockYoY
628.70 MUSD+2.43%
613.81 MUSD+1.49%
604.77 MUSD+1.90%
593.49 MUSD+2.12%
581.17 MUSD+2.36%
567.79 MUSD+2.09%
556.16 MUSD+1.24%
549.33 MUSD+2.10%
538.05 MUSD+2.10%
526.99 MUSD+0.63%
523.67 MUSD+1.10%
518.00 MUSD+2.32%
506.25 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AngioDynamics stock

Treasury Stock of AngioDynamics is 628.70 M USD in 2026.

Treasury Stock of AngioDynamics changed from 613.81 M USD to 628.70 M USD, representing a 2.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's AngioDynamics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — AngioDynamics

All Key Metrics — AngioDynamics